PL337807A1
Sertralin dosage formulation in the form of a gelatine-encapsulated solution
Abstract
Dosage forms of sertraline encapsulated in a water-immiscible vehicle shorten Tmax and/or reduce side effects and/or decrease sertraline precipitation in chloride ion-containing use environments such as the gastrointestinal tract.
Term
Term ended
Projected expiry passed 16 June 2018, 8.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
56 members in 42 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 5140197 | United States of America | P | |
| 5140197 | United States of America | P | |
| 9800936 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 9800936 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 60051401 | – | – | – |
| IB9800936 | – | – | – |
| US19970051401P | – | – | – |
| WO1998IB00936 | – | – | – |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| MA24586A1 | Morocco | A1 | |
| CA2290973A1 | Canada | A1 | |
| WO9901113A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7545098A | Australia | A | |
| HRP980378A2 | Croatia | A2 | |
| PE97299A1 | Peru | A1 | |
| IS5266A | Iceland | A | |
| GT199800090A | Guatemala | A | |
| NO996492D0 | Norway | D0 | |
| ZA985709B | South Africa | B | |
| TW382597B | Taiwan Province of China | B | |
| EP0980241A1 | European Patent Office (EPO) | A1 | |
| NO996492L | Norway | L | |
| PA8454001A1 | Panama | A1 | |
| BR9809712A | Brazil | A | |
| CO4940405A1 | Colombia | A1 | |
| ID24673A | Indonesia | A | |
| BG103917A | Bulgaria | A | |
| CN1261792A | China | A | |
| TR199903282T2 | Türkiye | T2 | |
| EA199900963A1 | Eurasian Patent Organization (EAPO) | A1 | |
| PL337807A1This record | Poland | A1 | |
| JP2000512316A | Japan | A | |
| AU724635B2 | Australia | B2 | |
| HU0002250A2 | Hungary | A2 | |
| HUP0002250A2 | Hungary | A2 | |
| UY25070A1 | Uruguay | A1 | |
| SK180599A3 | Slovakia | A3 | |
| HU0002250A3 | Hungary | A3 | |
| HUP0002250A3 | Hungary | A3 | |
| KR20010013588A | Republic of Korea | A | |
| AP945A | African Regional Intellectual Property Organization (ARIPO) | A | |
| IL133075D0 | Israel | D0 | |
| AR015916A1 | Argentina | A1 | |
| EA001905B1 | Eurasian Patent Organization (EAPO) | B1 | |
| HRP980378B1 | Croatia | B1 | |
| OA11246A | African Intellectual Property Organization (OAPI) | A | |
| SK282914B6 | Slovakia | B6 | |
| KR100371730B1 | Republic of Korea | B1 | |
| DZ2544A1 | Algeria | A1 | |
| CA2290973C | Canada | C | |
| US2003133974A1 | United States of America | A1 | |
| EP0980241B1 | European Patent Office (EPO) | B1 | |
| AT256457T | Austria | T | |
| ATE256457T1 | Austria | T1 | |
| DE69820608D1 | Germany | D1 | |
| PT980241E | Portugal | E | |
| DK0980241T3 | Denmark | T3 | |
| SI0980241T1 | Slovenia | T1 | |
| ES2210760T3 | Spain | T3 | |
| UA68350C2 | Ukraine | C2 | |
| JP3585245B2 | Japan | B2 | |
| NZ501252A | New Zealand | A | |
| DE69820608T2 | Germany | T2 | |
| TNSN98123A1 | Tunisia | A1 | |
| MY119728A | Malaysia | A |
Numbers
- Publication, DOCDB
- 337807
- Publication, EPODOC
- PL337807
- Application
- 98337807
- Application, DOCDB
- 33780798
- Application, EPODOC
- PL19980337807
Titles
- English
- SERTRALIN DOSAGE FORMULATION IN THE FORM OF A GELATINE-ENCAPSULATED SOLUTION
Classification
- CPC, 9
- A61K9/4858
- A61K9/48
- A61K31/135
- A61P15/00
- A61P25/00
- A61P25/24
- A61P25/30
- A61P3/04
- A61P43/00
- IPC, 7
- A61K9 48
- A61K9 66
- A61K31 135
- A61P3 04
- A61P25 00
- A61P25 24
- A61P43 00